Cash flow The Clorox Company

Equities

CLX

US1890541097

Household Products

Real-time Estimate Cboe BZX Other stock markets 13:31:28 2025-12-05 EST			5-day change	1st Jan Change
104.82 ^USD	-0.26%		-2.88%	-35.45%

12-02	The Clorox Company Presents at Morgan Stanley Global Consumer & Retail Conference 2025, Dec-02-2025 02:15 PM
11-24	Clorox Insider Bought Shares Worth $416,516, According to a Recent SEC Filing	MT

1035.g-CnKQ4z6oIDpAHActYdggJBR9ma03n5PQEZgfH3-qg.75jLeToC2M1XynOhH6MuyVoFEL2sojWXckhI6qe9lfni0cN5eUWzzDrqRA

Published financial data: THE CLOROX COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	7.34B	7.11B	7.39B	7.09B	7.1B
Total Revenues	7.34B	7.11B	7.39B	7.09B	7.1B
Cost of Goods Sold, Total	4.14B	4.56B	4.48B	4.03B	3.9B
Gross Profit	3.2B	2.54B	2.9B	3.06B	3.21B
Selling General & Admin Expenses, Total	1.81B	1.68B	1.92B	1.98B	1.9B
R&D Expenses	149M	132M	139M	126M	121M
Other Operating Expenses	23M	8M	33M	33M	6M
Other Operating Expenses, Total	1.98B	1.82B	2.09B	2.14B	2.02B
Operating Income	1.22B	726M	812M	921M	1.18B
Interest Expense, Total	-99M	-106M	-90M	-90M	-88M
Interest And Investment Income	5M	5M	16M	23M	9M
Net Interest Expenses	-94M	-101M	-74M	-67M	-79M
Income (Loss) On Equity Invest.	5M	6M	4M	5M	4M
Currency Exchange Gains (Loss)	-10M	-3M	-13M	-25M	-2M
EBT, Excl. Unusual Items	1.12B	628M	729M	834M	1.11B
Restructuring Charges	-	-	-60M	-32M	-
Impairment of Goodwill	-228M	-	-306M	-	-
Gain (Loss) On Sale Of Investments	110M	-21M	14M	20M	18M
Gain (Loss) On Sale Of Assets	-	-	-	-224M	-118M
Asset Writedown	-101M	-	-139M	-	-
Insurance Settlements	-	-	-	-	70M
Other Unusual Items	-	-	-	-200M	-
EBT, Incl. Unusual Items	900M	607M	238M	398M	1.08B
Income Tax Expense	181M	136M	77M	106M	254M
Earnings From Continuing Operations	719M	471M	161M	292M	824M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	719M	471M	161M	292M	824M
Minority Interest	-9M	-9M	-12M	-12M	-14M
Net Income - (IS)	710M	462M	149M	280M	810M
Net Income to Common Incl Extra Items	710M	462M	149M	280M	810M
Net Income to Common Excl. Extra Items	710M	462M	149M	280M	810M
Per Share Items
Net EPS - Basic	5.65	3.75	1.21	2.25	6.56
Basic EPS - Continuing Operations	5.65	3.75	1.21	2.25	6.56
Basic Weighted Average Shares Outstanding	126M	123M	124M	124M	124M
Net EPS - Diluted	5.58	3.73	1.2	2.25	6.52
Diluted EPS - Continuing Operations	5.58	3.73	1.2	2.25	6.52
Diluted Weighted Average Shares Outstanding	127M	124M	124M	125M	124M
Normalized Basic EPS	5.5	3.12	3.59	4.1	5.49
Normalized Diluted EPS	5.42	3.1	3.57	4.08	5.46
Dividend Per Share	4.49	4.66	4.74	4.82	4.9
Payout Ratio	78.59	123.59	391.28	212.5	74.32
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	1.42B	942M	1.04B	1.15B	1.4B
EBITA	1.25B	757M	842M	950M	1.21B
EBIT	1.22B	726M	812M	921M	1.18B
EBITDAR	1.54B	1.11B	1.22B	1.34B	1.56B
Effective Tax Rate - (Ratio)	20.11	22.41	32.35	26.63	23.56
Current Domestic Taxes	172M	88M	186M	150M	204M
Current Foreign Taxes	41M	43M	40M	56M	68M
Total Current Taxes	213M	131M	226M	206M	272M
Deferred Domestic Taxes	-35M	4M	-148M	-104M	-19M
Deferred Foreign Taxes	3M	1M	-1M	4M	1M
Total Deferred Taxes	-32M	5M	-149M	-100M	-18M
Normalized Net Income	690M	384M	444M	509M	678M
Interest on Long-Term Debt	99M	1M	1M	1M	2M
Non-Cash Pension Expense	15M	16M	16M	186M	3M
Supplemental Operating Expense Items
Advertising Expense	790M	709M	734M	832M	770M
Selling and Marketing Expenses	790M	709M	734M	832M	770M
Research And Development Expense From Footnotes	149M	132M	138M	126M	121M
Net Rental Expense, Total	114M	169M	180M	194M	160M
Imputed Operating Lease Interest Expense	28.56M	45.44M	42.66M	47.42M	38.49M
Imputed Operating Lease Depreciation	85.44M	124M	137M	147M	122M
Stock-Based Comp., COGS (Total)	6M	6M	7M	7M	7M
Stock-Based Comp., R&D Exp. (Total)	4M	4M	5M	4M	4M
Stock-Based Comp., SG&A Exp. (Total)	40M	42M	61M	63M	70M
Total Stock-Based Compensation	50M	52M	73M	74M	81M

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	319M	183M	367M	202M	167M
Total Cash And Short Term Investments	319M	183M	367M	202M	167M
Accounts Receivable, Total	582M	659M	674M	656M	805M
Other Receivables	22M	22M	14M	39M	16M
Total Receivables	604M	681M	688M	695M	821M
Inventory	752M	755M	696M	637M	523M
Prepaid Expenses	145M	99M	75M	84M	92M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	9M	7M	2M	4M	5M
Total Current Assets	1.83B	1.72B	1.83B	1.62B	1.61B
Gross Property Plant And Equipment	4.04B	4.22B	4.42B	4.53B	4.55B
Accumulated Depreciation	-2.38B	-2.53B	-2.7B	-2.82B	-2.91B
Net Property Plant And Equipment	1.65B	1.69B	1.72B	1.71B	1.64B
Long-term Investments	79M	52M	43M	45M	47M
Goodwill	1.58B	1.56B	1.25B	1.23B	1.23B
Other Intangibles, Total	918M	884M	712M	681M	566M
Deferred Tax Assets Long-Term	-	-	147M	198M	167M
Other Long-Term Assets, Total	280M	245M	243M	269M	309M
Total Assets	6.33B	6.16B	5.94B	5.75B	5.56B
Liabilities
Accounts Payable, Total	930M	960M	1.21B	950M	967M
Accrued Expenses, Total	446M	375M	419M	346M	316M
Short-term Borrowings	-	237M	50M	4M	4M
Current Portion of Long-Term Debt	300M	-	-	-	-
Current Portion of Leases	86M	84M	96M	97M	102M
Current Income Taxes Payable	-	-	121M	-	-
Other Current Liabilities	294M	128M	23M	177M	530M
Total Current Liabilities	2.06B	1.78B	1.92B	1.57B	1.92B
Long-Term Debt	2.48B	2.47B	2.48B	2.48B	2.48B
Long-Term Leases	316M	327M	331M	355M	326M
Pension & Other Post Retirement Benefits	330M	263M	259M	263M	267M
Deferred Tax Liability Non Current	67M	66M	28M	22M	20M
Other Non Current Liabilities	489M	515M	545M	564M	63M
Total Liabilities	5.74B	5.43B	5.56B	5.26B	5.08B
Common Stock, Total	131M	131M	131M	131M	131M
Additional Paid In Capital	1.19B	1.2B	1.24B	1.29B	1.32B
Retained Earnings	1.04B	1.05B	583M	250M	432M
Treasury Stock	-1.4B	-1.35B	-1.25B	-1.19B	-1.4B
Comprehensive Income and Other	-546M	-479M	-493M	-155M	-157M
Total Common Equity	411M	556M	220M	328M	321M
Minority Interest	181M	173M	168M	164M	161M
Total Equity	592M	729M	388M	492M	482M
Total Liabilities And Equity	6.33B	6.16B	5.94B	5.75B	5.56B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	123M	123M	124M	124M	122M
ECS Total Common Shares Outstanding	123M	123M	124M	124M	123M
Book Value / Share	3.35	4.51	1.78	2.64	2.62
Tangible Book Value	-2.08B	-1.89B	-1.74B	-1.58B	-1.47B
Tangible Book Value Per Share	-16.96	-15.31	-14.08	-12.73	-12.01
Total Debt	3.19B	3.12B	2.95B	2.94B	2.92B
Net Debt	2.87B	2.94B	2.59B	2.74B	2.75B
Debt Equivalent of Unfunded Proj. Benefit Obligation	115M	101M	95M	98M	90M
Debt Equivalent Oper. Leases	912M	1.35B	1.44B	1.55B	1.28B
Minority Interest, Total (Incl. Fin. Div)	181M	173M	168M	164M	161M
Equity Method Investments, Total	55M	52M	43M	45M	47M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	-31M	-	-	-	-80M
Inventories - Raw Materials, Total	229M	-	-	-	141M
Inventories - Work In Process, Total	11M	-	-	-	15M
Inventories - Finished Goods, Total	543M	-	-	-	447M
Land - (BS)	148M	166M	168M	174M	169M
Buildings, Total	707M	729M	810M	816M	799M
Machinery, Total	2.21B	2.33B	2.49B	2.54B	2.63B
Full Time Employees	9K	9K	8.7K	8K	7.6K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	8M	9M	3M	5M	6M

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	710M	462M	149M	280M	810M
Depreciation & Amortization - CF	173M	185M	196M	196M	191M
Amortization of Goodwill and Intangible Assets - (CF)	32M	31M	30M	29M	21M
Depreciation & Amortization, Total	205M	216M	226M	225M	212M
Amortization of Deferred Charges, Total - (CF)	6M	8M	10M	10M	7M
(Gain) Loss From Sale Of Asset	-	-	-	238M	112M
Asset Writedown & Restructuring Costs	329M	-	445M	-	-
Stock-Based Compensation (CF)	50M	52M	73M	74M	81M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-13M	147M	-99M	109M	-30M
Change In Accounts Receivable	82M	-84M	-13M	-34M	-145M
Change In Inventories	-282M	-18M	58M	55M	63M
Change In Accounts Payable	311M	-47M	157M	-140M	-124M
Change In Income Taxes	-90M	35M	152M	-147M	2M
Change in Other Net Operating Assets	-32M	15M	0	25M	-7M
Cash from Operations	1.28B	786M	1.16B	695M	981M
Capital Expenditure	-331M	-251M	-228M	-212M	-220M
Cash Acquisitions	-85M	-	-	-	-
Divestitures	-	-	-	17M	128M
Other Investing Activities, Total	-36M	22M	5M	20M	-2M
Cash from Investing	-452M	-229M	-223M	-175M	-94M
Short Term Debt Issued, Total	-	237M	-	-	-
Long-Term Debt Issued, Total	-	1.08B	-	-	-
Total Debt Issued	-	1.32B	-	-	-
Short Term Debt Repaid, Total	-	-	-188M	-45M	-
Long-Term Debt Repaid, Total	-	-1.4B	-	-	-
Total Debt Repaid	-	-1.4B	-188M	-45M	-
Issuance of Common Stock	103M	5M	33M	1M	26M
Repurchase of Common Stock	-905M	-25M	-	-	-332M
Common Dividends Paid	-558M	-571M	-583M	-595M	-602M
Common & Preferred Stock Dividends Paid	-558M	-571M	-583M	-595M	-602M
Other Financing Activities, Total	-31M	-15M	-15M	-16M	-16M
Cash from Financing	-1.39B	-689M	-753M	-655M	-924M
Foreign Exchange Rate Adjustments	12M	-6M	-	-26M	-
Net Change in Cash	-555M	-138M	182M	-161M	-37M
Supplemental Items
Cash Interest Paid	89M	89M	99M	102M	97M
Cash Income Tax Paid (Refund)	303M	100M	73M	347M	264M
Levered Free Cash Flow	586M	174M	921M	359M	1.08B
Unlevered Free Cash Flow	648M	240M	978M	416M	1.14B
Change In Net Working Capital	43M	239M	-389M	257M	-319M
Net Debt Issued / Repaid	-	-83M	-188M	-45M	-

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	12.13	7.26	8.39	9.84	13.09
Return on Total Capital	19.46	11.9	14.11	17	21.7
Return On Equity %	95.87	71.31	28.83	66.36	169.2
Return on Common Equity	107.66	95.55	38.4	102.19	249.61
Margin Analysis
Gross Profit Margin %	43.58	35.81	39.32	43.21	45.16
SG&A Margin	24.64	23.62	26	27.99	26.69
EBITDA Margin %	19.38	13.25	14.05	16.16	19.66
EBITA Margin %	17.03	10.65	11.4	13.39	16.98
EBIT Margin %	16.59	10.22	10.99	12.98	16.68
Income From Continuing Operations Margin %	9.79	6.63	2.18	4.12	11.6
Net Income Margin %	9.67	6.5	2.02	3.95	11.4
Net Avail. For Common Margin %	9.67	6.5	2.02	3.95	11.4
Normalized Net Income Margin	9.4	5.4	6	7.18	9.55
Levered Free Cash Flow Margin	7.99	2.44	12.47	5.07	15.27
Unlevered Free Cash Flow Margin	8.83	3.37	13.23	5.86	16.04
Asset Turnover
Asset Turnover	1.17	1.14	1.22	1.21	1.26
Fixed Assets Turnover	4.8	4.25	4.33	4.14	4.25
Receivables Turnover (Average Receivables)	12.13	11.45	11.09	10.67	9.72
Inventory Turnover (Average Inventory)	6.87	6.05	6.18	6.04	6.72
Short Term Liquidity
Current Ratio	0.89	0.97	0.95	1.03	0.84
Quick Ratio	0.45	0.48	0.55	0.57	0.51
Operating Cash Flow to Current Liabilities	0.62	0.44	0.6	0.44	0.51
Days Sales Outstanding (Average Receivables)	30.08	31.87	32.92	34.31	37.53
Days Outstanding Inventory (Average Inventory)	53.14	60.29	59.06	60.56	54.34
Average Days Payable Outstanding	61.86	75.56	93.91	90.88	99.74
Cash Conversion Cycle (Average Days)	21.36	16.6	-1.93	4	-7.87
Long Term Solvency
Total Debt/Equity	538.18	428.26	761.34	596.95	604.98
Total Debt / Total Capital	84.33	81.07	88.39	85.65	85.82
LT Debt/Equity	472.97	384.22	723.71	576.42	582.99
Long-Term Debt / Total Capital	74.11	72.73	84.02	82.71	82.7
Total Liabilities / Total Assets	90.65	88.16	93.47	91.44	91.33
EBIT / Interest Expense	12.3	6.85	9.02	10.23	13.47
EBITDA / Interest Expense	15.53	10.48	13.53	14.89	17.69
(EBITDA - Capex) / Interest Expense	12.18	8.11	11	12.53	15.19
Total Debt / EBITDA	2.07	2.81	2.43	2.19	1.87
Net Debt / EBITDA	1.87	2.65	2.12	2.04	1.77
Total Debt / (EBITDA - Capex)	2.64	3.63	2.98	2.6	2.18
Net Debt / (EBITDA - Capex)	2.38	3.42	2.61	2.42	2.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.22	-3.19	3.97	-4.01	0.16
Gross Profit, 1 Yr. Growth %	4.44	-20.44	14.15	5.51	4.67
EBITDA, 1 Yr. Growth %	-0.21	-33.8	11.85	10.4	21.9
EBITA, 1 Yr. Growth %	-1.19	-39.44	13.32	12.83	26.95
EBIT, 1 Yr. Growth %	-2.64	-40.39	14.04	13.42	28.66
Earnings From Cont. Operations, 1 Yr. Growth %	-23.43	-34.49	-65.82	81.37	182.19
Net Income, 1 Yr. Growth %	-24.39	-34.93	-67.75	87.92	189.29
Normalized Net Income, 1 Yr. Growth %	-5.35	-44.45	18.38	14.79	33.24
Diluted EPS Before Extra, 1 Yr. Growth %	-24.18	-33.15	-67.83	87.5	189.78
Accounts Receivable, 1 Yr. Growth %	-7.32	13.23	2.28	-2.67	22.71
Inventory, 1 Yr. Growth %	65.64	0.4	-7.81	-8.48	-17.9
Net Property, Plant and Equip., 1 Yr. Growth %	17.4	2.48	1.53	-0.7	-4.27
Total Assets, 1 Yr. Growth %	1.95	-2.78	-3.46	-3.26	-3.3
Tangible Book Value, 1 Yr. Growth %	33.21	-9.41	-7.53	-9.35	-6.77
Common Equity, 1 Yr. Growth %	-54.74	35.28	-60.43	49.09	-2.13
Cash From Operations, 1 Yr. Growth %	-17.46	-38.4	47.33	-39.98	41.15
Capital Expenditures, 1 Yr. Growth %	30.31	-24.17	-9.16	-7.02	3.77
Levered Free Cash Flow, 1 Yr. Growth %	-44.1	-70.41	459.18	-60.99	201.81
Unlevered Free Cash Flow, 1 Yr. Growth %	-41.65	-63.02	323.16	-57.48	174.2
Dividend Per Share, 1 Yr. Growth %	4.66	3.79	1.72	1.69	1.66
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.69	2.83	0.33	-0.1	-1.95
Gross Profit, 2 Yr. CAGR %	8.29	-8.85	-4.91	9.74	5.09
EBITDA, 2 Yr. CAGR %	5.6	-18.72	-15.01	11.13	16.01
EBITA, 2 Yr. CAGR %	5.69	-22.64	-18.38	13.08	19.68
EBIT, 2 Yr. CAGR %	5.04	-23.82	-18.82	13.73	20.8
Earnings From Cont. Operations, 2 Yr. CAGR %	-6.36	-29.18	-52.68	-21.26	126.23
Net Income, 2 Yr. CAGR %	-6.95	-29.86	-54.19	-22.15	133.16
Normalized Net Income, 2 Yr. CAGR %	4.17	-27.49	-20.34	16.57	23.67
Diluted EPS Before Extra, 2 Yr. CAGR %	-6.04	-28.81	-53.63	-22.33	133.1
Accounts Receivable, 2 Yr. CAGR %	-2.64	2.44	7.61	-0.23	9.29
Inventory, 2 Yr. CAGR %	21.19	28.96	-3.8	-8.15	-13.31
Net Property, Plant and Equip., 2 Yr. CAGR %	26.44	9.69	2.01	0.41	-2.5
Total Assets, 2 Yr. CAGR %	11.27	-0.44	-3.12	-3.36	-3.28
Tangible Book Value, 2 Yr. CAGR %	3.49	9.85	-8.48	-8.44	-8.07
Common Equity, 2 Yr. CAGR %	-14.25	-21.75	-26.84	-23.19	20.79
Cash From Operations, 2 Yr. CAGR %	13.41	-28.7	-4.74	-5.97	-7.96
Capital Expenditures, 2 Yr. CAGR %	26.76	-0.59	-17	-8.1	-1.77
Levered Free Cash Flow, 2 Yr. CAGR %	-6.82	-59.33	24.42	47.69	8.51
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.15	-53.54	21.98	34.14	7.97
Dividend Per Share, 2 Yr. CAGR %	6.75	4.22	2.75	1.7	1.67
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.23	4.58	3.21	-1.14	-0.01
Gross Profit, 3 Yr. CAGR %	6.14	-2.29	-1.75	-1.56	8.02
EBITDA, 3 Yr. CAGR %	3.59	-9.62	-10.04	-7.27	14.61
EBITA, 3 Yr. CAGR %	3.27	-12.21	-12.69	-9.08	17.52
EBIT, 3 Yr. CAGR %	2.68	-13.04	-13.42	-9.24	18.51
Earnings From Cont. Operations, 3 Yr. CAGR %	-4.4	-16.87	-44.45	-25.95	20.49
Net Income, 3 Yr. CAGR %	-4.8	-17.41	-45.86	-26.67	20.58
Normalized Net Income, 3 Yr. CAGR %	1.54	-15.53	-15.27	-10.02	21.88
Diluted EPS Before Extra, 3 Yr. CAGR %	-3.76	-16.12	-45.37	-26.12	20.46
Accounts Receivable, 3 Yr. CAGR %	-0.45	2.39	2.38	4.07	6.9
Inventory, 3 Yr. CAGR %	14.12	13.82	15.31	-5.38	-11.52
Net Property, Plant and Equip., 3 Yr. CAGR %	18.4	17.89	6.9	1.1	-1.17
Total Assets, 3 Yr. CAGR %	7.77	6.37	-1.46	-3.17	-3.34
Tangible Book Value, 3 Yr. CAGR %	4.87	-1	3.72	-8.77	-7.89
Common Equity, 3 Yr. CAGR %	-17.28	-0.18	-37.66	-7.24	-16.73
Cash From Operations, 3 Yr. CAGR %	9.35	-7.47	-9.18	-18.33	7.67
Capital Expenditures, 3 Yr. CAGR %	19.49	6.81	-3.54	-13.8	-4.3
Levered Free Cash Flow, 3 Yr. CAGR %	-0.04	-36.43	-4.24	-15.48	87.42
Unlevered Free Cash Flow, 3 Yr. CAGR %	0.42	-31.19	-4.17	-14.16	70.24
Dividend Per Share, 3 Yr. CAGR %	7.64	5.75	3.38	2.39	1.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.97	3.54	3.83	2.68	1.11
Gross Profit, 5 Yr. CAGR %	4.25	-0.96	1.66	2.36	0.93
EBITDA, 5 Yr. CAGR %	3.47	-5.61	-4.1	-2.13	-0.41
EBITA, 5 Yr. CAGR %	3.37	-7.52	-5.8	-3.22	-0.95
EBIT, 5 Yr. CAGR %	2.99	-8.12	-6.31	-3.56	-1.08
Earnings From Cont. Operations, 5 Yr. CAGR %	2.1	-7.7	-27.84	-18.66	-2.58
Net Income, 5 Yr. CAGR %	1.84	-8	-28.95	-19.34	-2.91
Normalized Net Income, 5 Yr. CAGR %	2.38	-10.1	-7.62	-4.36	-1.44
Diluted EPS Before Extra, 5 Yr. CAGR %	2.55	-6.96	-28.13	-18.66	-2.39
Accounts Receivable, 5 Yr. CAGR %	0.77	3.24	2.7	1.33	5.09
Inventory, 5 Yr. CAGR %	11.16	10.47	6.58	4.47	2.87
Net Property, Plant and Equip., 5 Yr. CAGR %	12.78	12.72	11.55	10.56	3.03
Total Assets, 5 Yr. CAGR %	7.03	6.13	3.28	2.37	-2.19
Tangible Book Value, 5 Yr. CAGR %	4.95	6.51	-0.69	-4.05	-1.17
Common Equity, 5 Yr. CAGR %	6.71	0.51	-21.24	-10.11	-18.78
Cash From Operations, 5 Yr. CAGR %	10.4	-1.9	3.48	-6.87	-8.7
Capital Expenditures, 5 Yr. CAGR %	13.99	1.67	3.28	0.58	-2.83
Levered Free Cash Flow, 5 Yr. CAGR %	-1.36	-21.42	9.43	-11.85	0.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.04	-17.68	8.84	-10.8	0.51
Dividend Per Share, 5 Yr. CAGR %	7.62	7.54	5.66	4.11	2.69